A critical view on lactose-based drug formulation and device studies for dry powder inhalation: Which are relevant and what interactions to expect?

被引:131
作者
de Boer, A. H. [1 ]
Chan, H. K. [2 ]
Price, R. [3 ]
机构
[1] Univ Groningen, Dept Pharmaceut Technol & Biopharm, NL-9713 AV Groningen, Netherlands
[2] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[3] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
关键词
Adhesive mixtures; Carrier lactose; Drug formulation; Pulmonary drug deposition; Powder mixing; Dispersion; Inhaler development; CLASSIFIER TECHNOLOGY ACT; COMPUTATIONAL FLUID-DYNAMICS; IN-VITRO EVALUATION; AIR CLASSIFIER; PARTICLE-SIZE; CARRIER PARTICLES; ADHESIVE MIXTURES; SURFACE-ENERGY; INHALER FORMULATIONS; PHYSICAL-PROPERTIES;
D O I
10.1016/j.addr.2011.04.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many years of research have not led to a profound knowledge of the mechanisms involved in the formulation and dispersion of carrier based mixtures for inhalation. Although it is well understood that the mixing is a key process in DPI carrier based formulation, there remains a limited understanding of how blending processes affect in-process material properties and the resulting distribution of the drug in the final dosage form. A great number of variables are considered relevant to the interfacial forces in adhesive mixtures, but their effects have mostly been investigated individually, without taking account of the influence they may have on each other. Interactions may be expected and without proper choices made and definitions given for all the variables involved, conclusions from studies on adhesive mixtures are of less relevance. By varying any of the variables that are not subject of the study, an opposite effect may be obtained. Currently, there is a strong focus on exploring techniques for the characterisation of drug and carrier surface properties that are believed to have an influence on the interparticulate forces in adhesive mixtures. For a number of surface properties it may be questioned whether they are really the key parameters to investigate however. Their orders of magnitude are subordinate to the effects they are supposed to have on the drug-to-carrier forces. Therefore, they seem rather indicators of other variability and their influence may be dominated by other effects. Finally, the relevance of inhaler design is often ignored. By using powerful inhalers, the effect of many variables of current concern may become less relevant. Carrier properties that are considered disadvantageous at present may even become desirable when a more appropriate type of dispersion force is applied. This can be shown for the effect of carrier surface rugosity when inertial separation forces are applied instead of the more widely applied lift and drag forces. Therefore, inhaler design should be taken into consideration when evaluating studies on adhesive mixtures. It should also become an integral part of powder formulation for inhalation. (c) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:257 / 274
页数:18
相关论文
共 111 条
  • [1] Cospray dried antibiotics for dry powder lung delivery
    Adi, Handoko
    Young, Paul M.
    Chan, Hak-Kim
    Stewart, Peter
    Agus, Helen
    Traini, Daniela
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (08) : 3356 - 3366
  • [2] ARNOLD K, 1995, Patent No. 5478578
  • [3] The cohesive-adhesive balances in dry powder inhaler formulations I: Direct quantification by atomic force microscopy
    Begat, P
    Morton, DAV
    Staniforth, JN
    Price, R
    [J]. PHARMACEUTICAL RESEARCH, 2004, 21 (09) : 1591 - 1597
  • [4] Begat P., 2005, P DRUG DEL LUNGS 16, P234
  • [5] The effects of high shear blending on α-lactose monohydrate
    Bridson, R. H.
    Robbins, P. T.
    Chen, Y.
    Westerman, D.
    Gillham, C. R.
    Roche, T. C.
    Seville, J. P. K.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 339 (1-2) : 84 - 90
  • [6] Characterisation of small changes in the physical properties of powders of significance for dry powder inhaler formulations
    Buckton, G
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 26 (01) : 17 - 27
  • [7] PROPOSED UNIVERSAL HOMOGENEITY AND MIXING INDEX
    BUSLIK, D
    [J]. POWDER TECHNOLOGY, 1973, 7 (02) : 111 - 116
  • [8] Chan HK, 2006, J AEROSOL MED, V19, P21, DOI 10.1089/jam.2006.19.21
  • [9] Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols
    Chew, NYK
    Chan, HK
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (07) : 1098 - 1103
  • [10] Effect of amino acids on the dispersion of disodium cromoglycate powders
    Chew, NYK
    Shekunov, BY
    Tong, HHY
    Chow, AHL
    Savage, C
    Wu, J
    Chan, HK
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (10) : 2289 - 2300